Cargando…

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus

Detalles Bibliográficos
Autores principales:	Lan, Jiaming, Deng, Yao, Song, Jingdong, Huang, Baoying, Wang, Wenling, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235757/ https://www.ncbi.nlm.nih.gov/pubmed/30374826 http://dx.doi.org/10.1007/s12250-018-0064-8

Ejemplares similares

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
por: Deng, Yao, et al.
Publicado: (2018)

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
por: Jiaming, Lan, et al.
Publicado: (2017)

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
por: Chen, Yingzhu, et al.
Publicado: (2017)

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
por: Chen, Yingzhu, et al.
Publicado: (2017)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
por: Fathi, Anahita, et al.
Publicado: (2022)

Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
por: Kleine-Weber, Hannah, et al.
Publicado: (2019)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection
por: El-Kafrawy, Sherif A., et al.
Publicado: (2021)

A novel human coronavirus: Middle East respiratory syndrome human coronavirus
por: Geng, HeYuan, et al.
Publicado: (2013)

Biochemical Characterization of Middle East Respiratory Syndrome Coronavirus Spike Protein Proteolytic Processing
por: Whittaker, Gary R., et al.
Publicado: (2019)

In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein
por: Rhoades, Raina, et al.
Publicado: (2022)

Clinical significance of the serum IgM and IgG to SARS‐CoV‐2 in coronavirus disease‐2019
por: Wu, Li‐xiang, et al.
Publicado: (2020)

Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
por: Zhao, JianGuo, et al.
Publicado: (2023)

Single Amino Acid Substitution in the Receptor Binding Domain of Spike Protein Is Sufficient To Convert the Neutralization Profile between Ethiopian and Middle Eastern Isolates of Middle East Respiratory Coronavirus
por: Sugimoto, Satoko, et al.
Publicado: (2023)

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
por: Guo, Xiaojuan, et al.
Publicado: (2015)

Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model
por: Pletinck, Anneleen, et al.
Publicado: (2018)

Crystal structures of Middle East respiratory syndrome coronavirus (MERS-CoV) spike protein
Publicado: (2013)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
por: Rossignol, Jean-François
Publicado: (2016)

Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
por: Smit, Wouter L., et al.
Publicado: (2022)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets
por: Yang, Yang, et al.
Publicado: (2015)

A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets
por: Xiao, Yan, et al.
Publicado: (2022)

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection
por: Han, Hui-Ju, et al.
Publicado: (2018)

Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG
por: XU, WEIQUN, et al.
Publicado: (2014)

Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization
por: Wang, Bei, et al.
Publicado: (2020)

Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion
por: Noy, Ariela, et al.
Publicado: (2022)

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
por: Adney, Danielle R., et al.
Publicado: (2019)

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
por: Xia, Shuai, et al.
Publicado: (2014)

Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies
por: Lester, Sandra, et al.
Publicado: (2019)

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
por: Raadsen, Matthijs P, et al.
Publicado: (2023)

Significance of IgG-Avidity in Antenatal Rubella Diagnosis
por: Agbede, Olajide Olubunmi, et al.
Publicado: (2013)

Differences in the seasonality of Middle East respiratory syndrome coronavirus and influenza in the Middle East
por: He, Daihai, et al.
Publicado: (2015)

Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro
por: Yang, Ren, et al.
Publicado: (2020)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

TRIM21 chimeric protein as a new molecular tool for multispecies IgG detection
por: Ramos, Anelize Felicio, et al.
Publicado: (2022)

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19
por: Wang, Gang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3p58r8uu0fhijigokhrfe7p7a